Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies
Open Access
- 17 February 2021
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 11 (2) , 298
Abstract
The complement system is part of the innate immune response, where it provides immediate protection from infectious agents and plays a fundamental role in homeostasis. Complement dysregulation occurs in several diseases, where the tightly regulated proteolytic cascade turns offensive. Prominent examples are atypical hemolytic uremic syndrome, paroxysmal nocturnal hemoglobinuria and Alzheimer’s disease. Therapeutic intervention targeting complement activation may allow treatment of such debilitating diseases. In this review, we describe a panel of complement targeting nanobodies that allow modulation at different steps of the proteolytic cascade, from the activation of the C1 complex in the classical pathway to formation of the C5 convertase in the terminal pathway. Thorough structural and functional characterization has provided a deep mechanistic understanding of the mode of inhibition for each of the nanobodies. These complement specific nanobodies are novel powerful probes for basic research and offer new opportunities for in vivo complement modulation.Keywords
All Related Versions
Funding Information
- Lundbeck Foundation (R155-2015-2666, R192-2015-726)
- Novo Nordisk Fonden (NNF16OC0022058)
This publication has 132 references indexed in Scilit:
- Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical PhenotypeJournal of the American Society of Nephrology, 2013
- Structural basis for activation of the complement system by component C4 cleavageProceedings of the National Academy of Sciences, 2012
- Causes of Alternative Pathway Dysregulation in Dense Deposit DiseaseClinical Journal of the American Society of Nephrology, 2012
- The Human C1q Globular Domain: Structure and Recognition of Non-Immune Self LigandsFrontiers in Immunology, 2012
- Substrate recognition by complement convertases revealed in the C5–cobra venom factor complexThe EMBO Journal, 2011
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase FormationScience, 2010
- Complement Protein C1q Forms a Complex with Cytotoxic Prion Protein OligomersJournal of Biological Chemistry, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorNature Immunology, 2009
- Structure of complement fragment C3b–factor H and implications for host protection by complement regulatorsNature Immunology, 2009